Research Site

Jiamusi 154007

2 studies enrolling now · 2 studies all time

What they study most

Carcinoma, Non-Small Cell Lung, Non-small Cell Lung Cancer (NSCLC)

Studies at this site

• A Global Phase III Study of Rilvegostomig or Pembrolizumab Monotherapy for First-Line Treatment of PD-L1-high Metastatic Non-small Cell Lung Cancer — Recruiting now
• Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations — Recruiting now